{"id":"https://openalex.org/W2035948588","doi":"https://doi.org/10.1158/1538-7445.am2012-1939","title":"Abstract 1939: TL32711, a novel Smac mimetic, exerts significant antitumor efficacy in primary pancreatic adenocarcinoma model","display_name":"Abstract 1939: TL32711, a novel Smac mimetic, exerts significant antitumor efficacy in primary pancreatic adenocarcinoma model","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2035948588","doi":"https://doi.org/10.1158/1538-7445.am2012-1939","mag":"2035948588"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-1939","doi":"https://doi.org/10.1158/1538-7445.am2012-1939","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1939","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025469479","display_name":"Wen Wee Ma","orcid":"https://orcid.org/0000-0001-5899-4034","observed_orcids":["https://orcid.org/0000-0001-5899-4034"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wen Wee Ma","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hao Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hao Zhang","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085199635","display_name":"Bonnie Lee Hylander","orcid":"https://orcid.org/0000-0002-0836-1893","observed_orcids":["https://orcid.org/0000-0002-0836-1893"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bonnie Hylander","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035002650","display_name":"Charles LeVea","orcid":"https://orcid.org/0000-0001-7443-0968","observed_orcids":["https://orcid.org/0000-0001-7443-0968"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles LeVea","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029344793","display_name":"Elizabeth A. Repasky","orcid":"https://orcid.org/0000-0002-9554-4152","observed_orcids":["https://orcid.org/0000-0002-9554-4152"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Repasky","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110133665","display_name":"David Edward Weng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160236","display_name":"TetraLogic Pharmaceuticals (United States)","ror":"https://ror.org/00a8x0890","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Weng","raw_affiliation_strings":["2TetraLogic Pharmaceuticals, Malvern, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2TetraLogic Pharmaceuticals, Malvern, PA","institution_ids":["https://openalex.org/I4210160236"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Burns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160236","display_name":"TetraLogic Pharmaceuticals (United States)","ror":"https://ror.org/00a8x0890","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Burns","raw_affiliation_strings":["2TetraLogic Pharmaceuticals, Malvern, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2TetraLogic Pharmaceuticals, Malvern, PA","institution_ids":["https://openalex.org/I4210160236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076733355","display_name":"Srinivas K. Chunduru","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160236","display_name":"TetraLogic Pharmaceuticals (United States)","ror":"https://ror.org/00a8x0890","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivas Chunduru","raw_affiliation_strings":["2TetraLogic Pharmaceuticals, Malvern, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2TetraLogic Pharmaceuticals, Malvern, PA","institution_ids":["https://openalex.org/I4210160236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110517","display_name":"Martin A. Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160236","display_name":"TetraLogic Pharmaceuticals (United States)","ror":"https://ror.org/00a8x0890","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Graham","raw_affiliation_strings":["2TetraLogic Pharmaceuticals, Malvern, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2TetraLogic Pharmaceuticals, Malvern, PA","institution_ids":["https://openalex.org/I4210160236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062284417","display_name":"Gerald J. Fetterly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald Fetterly","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109121383","display_name":"Mark A. McKinlay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160236","display_name":"TetraLogic Pharmaceuticals (United States)","ror":"https://ror.org/00a8x0890","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark McKinlay","raw_affiliation_strings":["2TetraLogic Pharmaceuticals, Malvern, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2TetraLogic Pharmaceuticals, Malvern, PA","institution_ids":["https://openalex.org/I4210160236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Adjei","raw_affiliation_strings":["1Roswell Park Cancer Inst., Buffalo, NY","1Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Cancer Inst., Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"1939","last_page":"1939"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smac-mimetics","display_name":"IAP antagonists","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.460999995470047},{"id":"https://openalex.org/keywords/panc-1-cells","display_name":"PANC-1 cells","score":0.6470000147819519},{"id":"https://openalex.org/keywords/caspase-3-activation","display_name":"caspase-3 activation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.6610000133514404},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7400000095367432},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6060000061988831},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3700000047683716},{"id":"https://openalex.org/keywords/death-receptor-signaling","display_name":"death receptor signaling","score":0.527999997138977},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3269999921321869}],"concepts":[{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.8071109652519226},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.742387592792511},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6108690500259399},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5151190161705017},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.4762080907821655},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4685301184654236},{"id":"https://openalex.org/C12519072","wikidata":"https://www.wikidata.org/wiki/Q14914370","display_name":"Caspase 3","level":4,"score":0.46327659487724304},{"id":"https://openalex.org/C2780070996","wikidata":"https://www.wikidata.org/wiki/Q61482373","display_name":"Trypan blue","level":3,"score":0.45545142889022827},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.42819347977638245},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42122793197631836},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.3492383360862732},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.34322136640548706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28527259826660156},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2837724983692169},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-1939","doi":"https://doi.org/10.1158/1538-7445.am2012-1939","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1939","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8700000047683716,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1972571046","https://openalex.org/W2089923741","https://openalex.org/W1964436731","https://openalex.org/W2000378207","https://openalex.org/W2165737898","https://openalex.org/W2035978582","https://openalex.org/W1992991433","https://openalex.org/W2154065774","https://openalex.org/W2323484115","https://openalex.org/W1977653352"],"abstract_inverted_index":{"Abstract":[0],"Introduction.":[1],"Pancreatic":[2],"cancer":[3,17,66,248,365,395],"is":[4,40,339,379],"highly":[5],"resistant":[6],"to":[7,24,27,162,191,233],"treatment.":[8],"Inhibitors":[9],"of":[10,59,77,147,245,287,337,406,411],"apoptosis":[11,48],"(IAPs)":[12],"were":[13,22,96,117,140,153,173,254,333],"overexpressed":[14],"in":[15,85,98,127,186,194,208,209,226,239,274,289,298,308,334,341,363,381,386,393],"pancreatic":[16,65,101,138,247,364,394],"cells":[18],"and":[19,33,49,80,89,109,114,155,170,196,235,258,271,273,325,372],"IAPs":[20],"downregulation":[21],"shown":[23],"induce":[25],"sensitivity":[26],"death":[28],"receptor":[29],"signaling,":[30],"cytotoxic":[31],"agents":[32],"radiation.":[34],"TL32711,":[35],"a":[36,41,62,198,282],"novel":[37],"Smac":[38],"mimetic,":[39],"potent":[42],"IAP":[43],"antagonist":[44],"that":[45,69,202,317,326,366],"induces":[46],"caspase-dependent":[47],"NFkB":[50],"canonical":[51],"pathway":[52],"inactivation.":[53],"Here,":[54],"we":[55],"investigated":[56],"the":[57,71,330,335,373,407,412],"efficacy":[58,166,319,362],"TL32711":[60,78,183,217,276,288,318,357,392],"using":[61],"patient-derived":[63],"primary":[64,100,137,213,228,291],"explant":[67,215],"model":[68],"mirrors":[70],"disease's":[72],"biological":[73],"heterogeneity.":[74],"Methods.":[75],"Effect":[76],"alone":[79],"with":[81,205,321,368],"TRAIL":[82,206],"was":[83,125,203,260,306],"evaluated":[84,141,154],"Panc1":[86],"by":[87,159],"immunoblotting":[88],"Trypan":[90],"blue":[91],"staining.":[92],"Dose":[93,278],"escalation":[94,177,279],"studies":[95,178,280],"performed":[97],"2":[99,240,290],"tumors":[102,139,152,157,229,343,382],"at":[103,130,142,219,310,329,344,383],"i.p.":[104],"30":[105],"mg/kg,":[106],"45":[107,312],"mg/kg":[108,111,221],"60":[110,143,220],"twice":[112],"weekly":[113],"tumor":[115,214,322,327,369,375],"volume":[116],"measured":[118],"for":[119,150,164,179,250,256,415],"28":[120],"days.":[121],"No":[122],"significant":[123,223,295,359],"toxicity":[124],"observed":[126],"tumor-bearing":[128],"mice":[129],"all":[131],"dose":[132,176],"levels.":[133],"An":[134],"additional":[135],"6":[136,227],"mg/kg.":[144,313],"H&E":[145,243],"slides":[146,244],"donor":[148,252],"patients":[149,253],"these":[151],"untreated":[156],"analyzed":[158],"gene":[160,350],"microarrays":[161],"explore":[163],"potential":[165],"biomarkers.":[167],"Tumor,":[168],"plasma":[169],"liver":[171],"samples":[172],"obtained":[174],"from":[175,349],"pharmacokinetic":[180],"analysis.":[181],"Results.":[182],"treatment":[184],"resulted":[185],"rapid":[187],"cIAP1":[188],"degradation":[189],"leading":[190],"caspase-3":[192],"activation":[193],"Panc1,":[195],"exerted":[197,222],"dose-dependent":[199,283],"pro-apoptotic":[200],"effect":[201,286],"synergized":[204],"co-incubation":[207],"vitro":[210],"studies.":[211,388],"In":[212],"studies,":[216],"dosed":[218],"growth":[224,237,284,296,304],"arrest/inhibition":[225],"(T/C":[230,241],"range":[231,336],"\u22120.1":[232],"0.2)":[234],"suboptimal":[236],"inhibition":[238,297,305],"\u223c0.4).":[242],"resected":[246],"specimens":[249],"7":[251],"available":[255],"evaluation,":[257],"there":[259],"no":[261],"relationship":[262],"between":[263],"histological":[264],"findings":[265],"(inflammatory":[266],"infiltrate,":[267],"stroma,":[268],"neutrophil/lymphocyte":[269],"ratio":[270],"necrosis)":[272],"vivo":[275],"efficacy.":[277],"showed":[281,316],"inhibitory":[285],"tumors:":[292],"30mg/kg":[293],"achieved":[294,307],"#17624":[299],"but":[300],"not":[301],"#12872.":[302],"Significant":[303],"both":[309],">=":[311],"Pharmacokinetic":[314],"analysis":[315,352],"correlated":[320,367],"drug":[323,370,376],"exposure":[324,377],"concentrations":[328],"effective":[331],"doses":[332,385],"what":[338],"achievable":[340,380],"patients\u2019":[342],"clinically":[345],"tolerable":[346],"doses.":[347],"Results":[348],"microarray":[351],"will":[353],"be":[354],"summarized.":[355],"Conclusions.":[356],"demonstrated":[358],"single":[360],"agent":[361],"exposure,":[371],"efficacious":[374],"here":[378],"tolerated":[384],"clinical":[387],"Clinical":[389],"trials":[390],"evaluating":[391],"are":[396],"planned.":[397],"Citation":[398],"Format:":[399],"{Authors}.":[400],"{Abstract":[401],"title}":[402],"[abstract].":[403],"In:":[404],"Proceedings":[405],"103rd":[408],"Annual":[409],"Meeting":[410],"American":[413],"Association":[414],"Cancer":[416,427],"Research;":[417],"2012":[418],"Mar":[419],"31-Apr":[420],"4;":[421],"Chicago,":[422],"IL.":[423],"Philadelphia":[424],"(PA):":[425],"AACR;":[426],"Res":[428],"2012;72(8":[429],"Suppl):Abstract":[430],"nr":[431],"1939.":[432],"doi:1538-7445.AM2012-1939":[433]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}